Autopsy report · NCT03707418

Bivalirudin vs Heparin in ECMO Patients

“unable to secure funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Extracorporeal Membrane Oxygenation Complication

Interventions

Heparin Sodium; Bivalirudin Injection [Angiomax]

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Androgen Regulation of Priapism in Sickle Cell Disease
  “Funding could not be secured” (92% match in meaning)
• Multicenter Exploratory Study of Accelerometry in Dilated Cardiomyopathy
  “Funding not secured” (91% match in meaning)
• Effects of Fish Oil on Post Ablation Arrhythmias
  “unable to secure funding and long term follow up” (88% match in meaning)
• Microbiome of Urologic Chronic Pelvic Pain Syndrome
  “Funding for project not secured” (87% match in meaning)
• Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C
  “No funding secured” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.